The standard combination of mRNA targeting elements, selected for high yield. The elements comprise 5' and 3' modules flanking the coding sequence (CDS) of the protein of interest (see figure below)
UTR®Tech has yield enhancing effect for most biopharmaceutical proteins, verified in industrial feasibility studies.
A panel of combinations of mRNA targeting elements, selected for high yield (see figure below).
The use of a 'Kit' containing multiple combinations allows identification of the best set of targeting elements for a particular protein.
A Research Evaluation License allows the user to carry out R&D testing of UTR®Tech/UTR®Betatech using an unlimited number of proteins
A Commercial License allows the user to apply UTR®Tech/UTR®Betatech to pre-clinical/clinical development programmes carried out to commercialize biopharmaceuticals and biosimilars
Our Tools can be accessed by contacting us at firstname.lastname@example.org.